Novartis

SANDIMMUNE

Manufacturer:

Novartis

Sandimmune HCPCS:

J7516

HCPCS Code Descriptor:

Cyclosporin, parenteral, 250 mg

Category:

J Code

Sandimmune NDCs:

00078-0109-01, 00078-0109-61

Primary Type:

Immunosuppressant

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Sandimmune:

SANDIMMUNE is an Immunosuppressant drug manufactured by Novartis and administered via the Intravenous route of administration. The J Code: J7516 is aligned to the drug SANDIMMUNE.

ACCESS PRICING AND MORE BY REGISTERING

J7516 Added Date:

January 1, 2000

J7516 Effective Date:

January 1, 2000

J7516 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Sandimmune billing and coding information.
Sandimmune patient assistance information can be found through Novartis Patient Support at the URL: https://www.novartis.com/us-en/patients-and-caregivers/patient-assistance/patient-assistance-foundation-enrollment
SANDIMMUNE prescribing information can be found at the link below:
Information regarding SANDIMMUNE’s side effects can be found at MedlinePlus